Genetics of rheumatoid arthritis: Time for a change!

Current Opinion in Rheumatology

Volumn 23, Issue 3, 2011, Pages 227-232

  De Vries, René ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

genetic epidemiology; genetics; human leukocyte antigen; immunogenetics; rheumatoid arthritis

Indexed keywords

ANTIBODY; ANTICITRULLINATED PROTEIN ANTIBODY; HLA ANTIGEN; UNCLASSIFIED DRUG;

COPY NUMBER VARIATION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOMICS; HERITABILITY; HUMAN; NONHUMAN; PATHOGENESIS; PHARMACOGENETICS; PREDICTION; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS;

ARTHRITIS, RHEUMATOID; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; HLA ANTIGENS; HUMANS; PHARMACOGENETICS;

EID: 79955004052     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/BOR.0b013e3283457524     Document Type: Review

References (72)

1. Plenge RM. Recent progress in rheumatoid arthritis genetics: one step towards improved patient care. Curr Opin Rheumatol 2009; 21:262-271.
2. Raychaudhuri S. Recent advances in the genetics of rheumatoid arthritis. Curr Opin Rheumatol 2010; 22:109-118.
3. Holoshitz J. The rheumatoid arthritis HLA-DRB1 shared epitope. Curr Opin Rheumatol 2010; 22:293-298.
4. MacGregor AJ, Snieder H, Rigby AS, et al. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum 2000; 43:30-37. (Pubitemid 30368210)
5. Van der Woude D, Houwing-Duistermaat JJ, Toes REM, et al. Quantitative heritability of anticitrullinated protein antibody-positive and anticitrullinated protein antibody-negative rheumatoid arthritis. Arthritis Rheum 2009; 60:916-923.
6. Van Asselt KM, Kok HS, van der Schouw YT, et al. Role of genetic analyses in cardiology. Part II: Heritability estimation for gene searching in multifactorial diseases. Circulation 2006; 113:1136-1139.
7. Deighton CM, Walker DJ, Griffiths ID, et al. The contribution of HLA to rheumatoid arthritis. Clin genet 1989; 36:178-182. (Pubitemid 19218460)
8. Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis: an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987; 30:1205-1213. (Pubitemid 18005792)
9. Van der Helm-van Mil AH, Huizinga TW, Schreuder GM, et al. An independent role of protective HLA class II alleles in rheumatoid arthritis severity and susceptibility. Arthritis Rheum 2005; 52:2637-2644. (Pubitemid 41369091)
10. Raychaudhuri S, Thomson BP, Remmers EF, et al. Common variants at CD40 and other loci confer risk of rheumatoid arthritis. Nat Genet 2008; 40:1216-1223.
11. Plenge RM, Raychaudhuri S. Leveraging human genetics to develop future therapeutic strategies in rheumatoid arthritis. Rheum Dis Clin North Am 2010; 36:259-270.
12. Raychaudhuri S, Thomson BP, Remmers EF, et al. Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk. Nat Genet 2009; 41:1313-1318.
13. Chang M, Rowland CM, Garcia VE, et al. A large-scale rheumatoid arthritis genetic study identifies association at chromosome 9q33.2. PLoS Genet 2008; 4:e1000107. doi: 10.1371/journal.pgen.1000107. (Pubitemid 351914798)
14. Barton A, Worthington J. Genetic susceptibility to rheumatoid arthritis: an emerging picture. Arthritis Rheum 2009; 61:1441-1446.
15. Silman AJ, Newman J, MacGregor AJ. Cigarette smoking increases the risk of rheumatoid arthritis: results from a nationwide study of disease-discordant twins. Arthritis Rheum 1996; 39:732-735. (Pubitemid 26140417)
16. Klareskog L, Padyukov L, Ronnelid J, Alfredsson L. Genes, environment and immunity in the development of rheumatoid arthritis. Curr Opin Immunol 2006; 18:650-655. (Pubitemid 44635174)
17. Claas FH, Gijbels Y, van der Velden-de Munck JJ, et al. Induction of B cell unresponsiveness to noninherited maternal HLA antigens during fetal life. Science 1988; 241:1815-1817.
18. ten Wolde S, Breedveld FC, de Vries RR, et al. Influence of noninherited maternal HLA antigens on occurrence of rheumatoid arthritis. Lancet 1993; 341:200-202. (Pubitemid 23048082)
19. Van der Horst-Bruinsma IE, Hazes JM, Schreuder GM, et al. Influence of noninherited maternal HLA-DR antigens on susceptibility to rheumatoid arthritis. Ann Rheum Dis 1998; 57:672-675. (Pubitemid 28558971)
20. Harney S, Newton J, Milicic A, et al. Noninherited maternal HLA alleles are associated with rheumatoid arthritis. Rheumatology (Oxford) 2003; 42:171-174. (Pubitemid 36131584)
21. Feitsma AL, Worthington J, Van der Helm-Van Mil AHM, et al. Protective effect of noninherited maternal HLA-DR antigens on rheumatoid arthritis development. Proc Natl Acad Sci USA 2007; 104:19966-19970.
22. Van der Woude D, Lie BA, Lundstrom E, et al. Protection against anticitrullinated protein antibody-positive rheumatoid arthritis is predominantly associated with HLA-DRB1-1301: a meta-analysis of HLA-DRB1 associations with anticitrullinated protein antibody-positive and anticitrullinated protein antibody-negative rheumatoid arthritis in four European populations. Arthritis Rheum 2010; 62:1236-1245.
23. Okada Y, Yamada R, Suzuki A, et al. Contribution of a haplotype in the HLA region to anticyclic citrullinated peptide antibody positivity in rheumatoid arthritis, independently of HLA-DRB1. Arthritis Rheum 2009; 60:3582-3590.
24. Okada Y, Suzuki A, Yamada R, et al. HLA-DRB1-0901 lowers anticyclic citrullinated peptide antibody levels in Japanese patients with rheumatoid arthritis. Ann Rheum Dis 2010; 69:1569-1570.
25. Yan Z, Aydelotte T, Gadi V, et al. Acquisition of the rheumatoid arthritis HLA shared epitope through microchimerism. Arthritis Rheum 2011; 63:640-644.
26. Rak JM, Maestroni L, Balandraud N, et al. Transfer of the shared epitope through microchimerism in women with rheumatoid arthritis. Arthritis Rheum 2009; 60:73-80.
27. Plant D, Flynn E, Mbarek H, et al. Investigation of potential non-HLA rheumatoid arthritis susceptibility loci in a European cohort increases the evidence for nine markers. Ann Rheum Dis 2010; 69:1548-1553.
28. Stahl EA, Raychaudhuri S, Remmers EF, et al. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet 2010; 42:508-514.
29. Kochi Y, Okada Y, Suzuki A, et al. A regulatory variant in CCR6 is associated with rheumatoid arthritis susceptibility. Nat Genet 2010; 42:515-519.
30. Ockinger J, Stridh P, Beyeen AD, et al. Genetic variants of CC chemokine genes in experimental autoimmune encephalomyelitis, multiple sclerosis and rheumatoid arthritis. Genes Immun 2010; 11:142-154.
31. Briggs FB, Ramsay PP, Madden E, et al. Supervised machine learning and logistic regression identifies novel epistatic risk factors with PTPN22 for rheumatoid arthritis. Genes Immun 2010; 11:199-208.
32. Martin JE, Alizadeh BZ, Gonzalez-Gay MA, et al. Identification of the oxidative stress-related gene MSRA as a rheumatoid arthritis susceptibility locus by genome-wide pathway analysis. Arthritis Rheum 2010; 62:3183-3190.
33. OrozcoG, Eyre S, Hinks A, et al. Study of the common genetic background for rheumatoid arthritis and systemic lupus erythematosus. Ann Rheum Dis 2011; 70:463-468.
34. Coenen MJ, Trynka G, Heskamp S, et al. Common and different genetic background for rheumatoid arthritis and coeliac disease. Hum Mol Genet 2009; 18:4195-4203.
35. Bang SY, Han TU, Choi CB, et al. Peptidyl arginine deiminase type IV (PADI4) haplotypes interact with shared epitope regardless of anticyclic citrullinated peptide antibody or erosive joint status in rheumatoid arthritis: a case-control study. Arthritis Res Ther 2010; 12:R115.
36. Van der Helm-Van Mil AH, Toes RE, Huizinga TW. Genetic variants in the prediction of rheumatoid arthritis. Ann Rheum Dis 2010; 69:1694-1696.
37. McClure A, Lunt M, Eyre S, et al. Investigating the viability of genetic screening/testing for RA susceptibility using combinations of five confirmed risk loci. Rheumatology (Oxford) 2009; 48:1369-1374.
38. Lu Q, Cui Y, Ye C, et al. Bagging optimal ROC curve method for predictive genetic tests, with an application for rheumatoid arthritis. J Biopharm Stat 2010; 20:401-414.
39. Craddock N, Hurles ME, Cardin N, et al. Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls. Nature 2010; 464:713-720.
40. Feng T, Zhu X. Genome-wide searching of rare genetic variants in WTCCC data. Hum Genet 2010; 128:269-280.
41. Ashley EA, Butte AJ, Wheeler MT, et al. Clinical assessment incorporating a personal genome. Lancet 2010; 375:1525-1535.
42. Docampo E, Rabionet R, Riveira-Munoz E, et al. Deletion of the late cornified envelope genes, LCE3C and LCE3B, is associated with rheumatoid arthritis. Arthritis Rheum 2010; 62:1246-1251.
43. Lindberg J, Wijbrandts CA, Van Baarsen LG, et al. The gene expression profile in the synovium as a predictor of the clinical response to infliximab treatment in rheumatoid arthritis. PLoS One 2010; 5:e11310.
44. Plant D, Bowes J, Potter C, et al. Genome-wide association study of genetic predictors of antitumour necrosis factor (TNF) treatment in rheumatoid arthritis (RA) identifies associations with polymorphisms at seven loci. Arthritis Rheum 2011; 63:645-653.
45. Coulthard LR, Taylor JC, Eyre S, et al. Genetic variants within the MAP kinase signalling network and anti-TNF treatment response in rheumatoid arthritis patients. Ann Rheum Dis 2011; 70:98-103.
46. Potter C, Cordell HJ, Barton A, et al. Association between antitumour necrosis factor treatment response and genetic variants within the TLR and NF{kappa}B signalling pathways. Ann Rheum Dis 2010; 69:1315-1320.
47. Tan RJ, Gibbons LJ, Potter C, et al. Investigation of rheumatoid arthritis susceptibility genes identifies association of AFF3 and CD226 variants with response to antitumour necrosis factor treatment. Ann Rheum Dis 2010; 69:1029-1035.
48. Xiao H, Xu J, Zhou X, et al. Associations between the genetic polymorphisms of MTHFR and outcomes of methotrexate treatment in rheumatoid arthritis. Clin Exp Rheumatol 2010; 28:728-733.
49. Cutolo M, Villaggio B, Pizzorni C, et al. Inflammatory gene profile in early rheumatoid arthritis and modulation by leflunomide and prednisone treatment. Ann N Y Acad Sci 2010; 1193:15-21.
50. Marsal S, Julia A. Rheumatoid arthritis pharmacogenomics. Pharmacogenomics 2010; 11:617-619.
51. Bienkowska JR, Dalgin GS, Batliwalla F, et al. Convergent Random Forest predictor: methodology for predicting drug response from genome-scale data applied to anti-TNF response. Genomics 2009; 94:423-432.
52. Qian Z, Latham KA, Whittington KB, et al. An autoantigen-specific, highly restricted T cell repertoire infiltrates the arthritic joints of mice in an HLA-DR1 humanized mouse model of autoimmune arthritis. J Immunol 2010; 185:110-118.
53. Li J, Kuzin I, Moshkani S, et al. Expanded CD23(\+)/CD21(hi) B cells in inflamed lymph nodes are associated with the onset of inflammatory-erosive arthritis in TNF-transgenic mice and are targets of anti-CD20 therapy. J Immunol 2010; 184:6142-6150.
54. Van der Woude D, Alemayehu WG, Verduijn W, et al. Gene-environment interaction influences the reactivity of autoantibodies to citrullinated antigens in rheumatoid arthritis. Nat Genet 2010; 42:814-816.
55. Bang SY, Lee KH, Cho SK, et al. Smoking increases rheumatoid arthritis susceptibility in individuals carrying the HLA-DRB1 shared epitope, regardless of rheumatoid factor or anticyclic citrullinated peptide antibody status. Arthritis Rheum 2010; 62:369-377.
56. Salliot C, Bombardier C, Saraux A, et al. Hormonal replacement therapy may reduce the risk for RA in women with early arthritis who carry HLA-DRB1-01 and/or-04 alleles by protecting against the production of anti-CCP: results from the ESPOIR cohort. Ann Rheum Dis 2010; 69:1683-1686.
57. Berglin E, Kokkonen H, Einarsdottir E, et al. Influence of female hormonal factors, in relation to autoantibodies and genetic markers, on the development of rheumatoid arthritis in northern Sweden: a case-control study. Scand J Rheumatol 2010; 39:454-460.
58. Elsby LM, Orozco G, Denton J, et al. Functional evaluation of TNFAIP3 (A20) in rheumatoid arthritis. Clin Exp Rheumatol 2010; 28:708-714.
59. Mahdi H, Fisher BA, Kallberg H, et al. Specific interaction between genotype, smoking and autoimmunity to citrullinated alpha-enolase in the etiology of rheumatoid arthritis. Nat Genet 2009; 41:1319-1324.
60. James EA, Moustakas AK, Bui J, et al. HLA-DR1001 presents 'altered-self' peptides derived from joint-associated proteins by accepting citrulline in three of its binding pockets. Arthritis Rheum 2010; 62:2909-2918.
61. Hill JA, Southwood S, Sette A, et al. Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1-0401 MHC class II molecule. J Immunol 2003; 171:538-541. (Pubitemid 36871358)
62. Feitsma AL, Van der Voort EI, Franken KL, et al. Identification of citrullinated vimentin peptides as T cell epitopes in HLA-DR4-positive patients with rheumatoid arthritis. Arthritis Rheum 2010; 62:117-125.
63. Manolio TA, Collins FS, Cox NJ, et al. Finding the missing heritability of complex diseases. Nature 2009; 461:747-753.
64. Thomas GP, Brown MA. Genetics and genomics of ankylosing spondylitis. Immunol Rev 2009; 233:162-180.
65. International Consortium for Systemic Lupus erythematosus Genetics (SLEGEN). Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 2008; 40:204-210.
66. Clayton DG. Prediction and interaction in complex disease genetics: experience in type 1 diabetes. PLoS Genet 2009; 5:e1000540; doi: 10.1371/ journal.pgen1000540.
67. Maher B. Personal genomes: the case of the missing heritability. Nature 2008; 456:18-21.
68. Casanova JL, Abel L. Revisiting Crohn's disease as a primary immunodefi-ciency of macrophages. J Exp Med 2009; 206:1839-1843.
69. Yang J, Benyamin B, McEvoy BP, et al. Common SNPs explain a large proportion of the heritability for human height. NatGenet 2010; 42:565-569.
70. Park JH, Wacholder S, Gail MH, et al. Estimation of effect size distribution from genome-wide association studies and implications for future discoveries. Nat Genet 2010; 42:570-575.
71. Gibson G. Hints of hidden heritability in GWAS. Nat Genet 2010; 42:558-560.
72. On beyond GWAS. Nat Genet 2010; 42:551.